Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical composition for losing weight or treating metabolic syndromes

A technology for metabolic syndrome and composition, which is applied in the fields of drug combination, metabolic diseases, pharmaceutical formulations, etc., can solve the problems such as no reports of orlistat or celistat combined with heparin drugs, etc. Lowering arterial pressure, overcoming increased pulse pressure, and reducing body weight

Active Publication Date: 2011-06-08
LUNAN PHARMA GROUP CORPORATION
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are no reports of orlistat or selistat combined with heparin drugs at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical composition for losing weight or treating metabolic syndromes
  • Medical composition for losing weight or treating metabolic syndromes
  • Medical composition for losing weight or treating metabolic syndromes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] prescription

[0016] Orlistat 150g

[0017] Ultra Low Molecular Heparin Sodium 50U

[0018] Microcrystalline Cellulose 200g

[0019] Appropriate amount of starch slurry

[0020] Low-substituted hydroxypropyl cellulose 190g

[0021] Magnesium Stearate 5g

[0022] Preparation process: Weigh the prescribed amount of orlistat, heparin sodium and other auxiliary materials, and prepare compressed tablets according to the conventional tablet preparation technology.

Embodiment 2

[0024] Orlistat 10g

[0025] Calcium Heparin 2500U

[0026] 100g pregelatinized starch

[0027] Mannitol 85g

[0028] Starch 50g

[0029] 6% PVP in 95% ethanol solution

[0030] Micronized silica gel 3.5g

[0031] Preparation process: Pass orlistat, heparin calcium, mannitol, starch and micropowder silica gel in the prescription through a 100-mesh sieve, mix well, add 6% PVP in 95% ethanol solution to granulate in appropriate amount, dry at 60°C, and dry for 18 Mesh sieve for granulation, then fill the capsules.

Embodiment 3

[0033] Orlistat 60g

[0034] Potassium Heparin 1000U

[0035] Croscarmell Starch Sodium 150g

[0036] Microcrystalline Cellulose 75g

[0037] Ethylcellulose 4g

[0038] Magnesium Stearate 4g

[0039] Preparation process: Weigh the prescribed amount of orlistat, heparin sodium and other auxiliary materials, and prepare compressed tablets according to the conventional sustained-release tablet preparation technology.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weight distributionaaaaaaaaaa
Login to View More

Abstract

The invention discloses a medical composition for treating metabolic syndromes, belonging to the field of medicines, and in particular relates to a medical composition containing orlistat or cetilistat and heparin, wherein the composition is solid preparations such as compressed tablets, dispersible tablets, sustained release tablets, capsules, granules, and the like. In experiments, the medical composition containing the orlistat or the cetilistat and the heparin is accidentally found to have obvious synergistic effect on the aspects of reducing the blood pressure, the serum total cholesterol, the serum triglyceride and the low density lipoprotein cholesterin and enhancing the carbohydrate tolerance.

Description

technical field [0001] The invention relates to a pharmaceutical composition for weight loss or treatment of metabolic syndrome, which belongs to the field of medicine. Background technique [0002] Overweight or obesity, accompanied by a series of diseases such as hypertension, hyperlipidemia, hyperglycemia, atherosclerosis and hyperinsulinemia, this phenomenon is called metabolic syndrome in medicine. Metabolic syndrome is a common physical problem faced by the urban population. It can not only increase the risk of diabetes and cardiovascular and cerebrovascular diseases, but also increase the mortality of cardiovascular and cerebrovascular diseases. Metabolic syndrome is a polygenic, hereditary disease and is influenced by the environment. Its clinical feature is the combination of obesity, dyslipidemia, hyperglycemia and hypertension. And these four kinds of diseases are often "collusion", which is the "death quartet" of modern urban people. Therefore, experts appeal ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/727A61K31/536A61K31/365A61P3/04A61P3/00A61P9/12
Inventor 赵志全李欣
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com